<< Back To Search

Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
This is a study where scientists are testing a new treatment for older people with a type of cancer called multiple myeloma. They want to see if using a special medicine called daratumumab can help treat the cancer.
*Third Opinion AI Generated Synopsis

Trial Summary
This is a Phase II study of daratumumab based therapies for older adults with multiple myeloma.

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Is There Anything Else You Would Like To Share?